853680-74-7 Usage
General Description
2-(4,6-Dichloropyrimidin-5-yl)ethanol, also known as 5-(2-hydroxyethyl)-4,6-dichloropyrimidine, is a chemical compound with the formula C7H6Cl2N2O. Its molecular weight is 217.04 g/mol. 2-(4,6-Dichloropyrimidin-5-yl)ethanol belongs to the class of organic compounds known as pyrimidines and pyrimidine derivatives, which are aromatic heterocyclic compounds containing a pyrimidine ring, which is a six-membered ring with two nitrogen atoms and four carbon atoms. It has two chloride groups bonded to the pyrimidine ring and an ethyl alcohol functional group at the 5 position of the ring. This chemical's properties have not been thoroughly studied, and its potential hazards and uses are not well-documented in the literature. Therefore, suitable safety precautions should be taken while handling the substance.
Check Digit Verification of cas no
The CAS Registry Mumber 853680-74-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,3,6,8 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 853680-74:
(8*8)+(7*5)+(6*3)+(5*6)+(4*8)+(3*0)+(2*7)+(1*4)=197
197 % 10 = 7
So 853680-74-7 is a valid CAS Registry Number.
853680-74-7Relevant articles and documents
Preparation method of 5-(2-bromoethyl)pyrimidine
-
Page/Page column 4-6, (2019/12/25)
The invention discloses a preparation method of 5-(2-bromoethyl) pyrimidine, and belongs to the field of medicinal chemistry. 5-acetaldehydeyl-4,6-dichloropyrimidine, sodium borohydride and thionyl bromide which are used as raw materials undergo a three-step reaction under the action of a catalyst Pd/C to obtain the target product 5-(2-bromoethyl)pyrimidine. The method has the advantages of simplicity in operation, mild reaction conditions, and environmental friendliness, makes the comprehensive yield reach 80% or above, and is suitable for industrial large-scale production.
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
-
Page/Page column 113, (2008/06/13)
This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
